In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species
Open Access
- 1 July 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 22 (1) , 165-166
- https://doi.org/10.1128/aac.22.1.165
Abstract
Metronidazole and its two principal oxidative metabolites were tested in vitro against 20 clinical isolates of the Bacteroides fragilis group. Both metabolites were bactericidal, and the exhibited 65 and 5%, respectively, of the inhibitory effect of metronidazole. Additive or weak synergistic effects resulted in combination with the parent compound.This publication has 7 references indexed in Scilit:
- Liquid chromatographic assay for metronidazole and tinidazole: pharmacokinetic and metabolic studies in human subjectsAntimicrobial Agents and Chemotherapy, 1981
- Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose.British Journal of Clinical Pharmacology, 1979
- Collaborative Evaluation of a Proposed Reference Dilution Method of Susceptibility Testing of Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1979
- Use of High-Pressure Liquid Chromatography to Determine Plasma Levels of Metronidazole and Metabolites After Intravenous AdministrationAntimicrobial Agents and Chemotherapy, 1978
- Medium for Use in Antibiotic Susceptibility Testing of Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1976
- Bioassay of Metronidazole with Either Anaerobic or Aerobic IncubationThe Journal of Infectious Diseases, 1975
- ANTAGONISTS OF NUCLEIC ACID DERIVATIVES .8. SYNERGISM IN COMBINATIONS OF BIOCHEMICALLY RELATED ANTIMETABOLITES1954